Pan, B., Huang, H., Wan, T., Huang, Q., He, S., Xu, S., . . . Zheng, M. The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: A retrospective real-world study. Frontiers Media S.A.
Chicago Style (17th ed.) CitationPan, Baoyue, et al. The Comparison of Efficacy and Safety Between Cadonilimab (PD-1/CTLA-4) and Anti-PD-1 Inhibitors in Patients with Recurrent or Metastatic Cervical Cancer: A Retrospective Real-world Study. Frontiers Media S.A.
MLA (9th ed.) CitationPan, Baoyue, et al. The Comparison of Efficacy and Safety Between Cadonilimab (PD-1/CTLA-4) and Anti-PD-1 Inhibitors in Patients with Recurrent or Metastatic Cervical Cancer: A Retrospective Real-world Study. Frontiers Media S.A.